Inmune Bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Inmune Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
  • Inmune Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.72M, a 9% decline year-over-year.
  • Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.37M, a 3.06% increase from 2022.
  • Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.15M, a 49.1% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.37M +$219K +3.06% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $7.15M +$2.35M +49.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $4.8M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.